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Abstract
Background: Childhood Meningitis continues to be an important cause of mortality in many countries. The search for rapid
diagnosis of acute bacterial meningitis has lead to the further exploration of prognostic factors. This study was scheduled in
an attempt to analyze various clinical symptoms as well as rapid laboratory results and provide an algorithm for the
prediction of specific bacterial aetiology of childhood bacterial meningitis.
Methodology and Principal Findings: During the 32 year period, 2477 cases of probable bacterial meningitis (BM) were
collected from the Meningitis Registry (MR). Analysis was performed on a total of 1331 confirmed bacterial meningitis cases
of patients aged 1 month to 14 years. Data was analysed using EPI INFO (version 3.4.3-CDC-Atlanta) and SPSS (version 15.0 -
Chicago) software. Statistically significant (p,0.05) variables were included in a conditional backward logistic regression
model. A total of 838 (63.0%) attributed to Neisseria meningitidis, 252 (18.9%) to Haemophilus influenzae, 186 (14.0%) to
Streptococcus pneumoniae and 55 (4.1%) due to other bacteria. For the diagnosis of Meningococcal Meningitis, the most
significant group of diagnostic criteria identified included haemorrhagic rash (OR 22.36), absence of seizures (OR 2.51),
headache (OR 1.83) and negative gram stain result (OR 1.55) with a Positive Predictive Value (PPV) of 96.4% (95%CI 87.7–
99.6). For the diagnosis of Streptococcus pneumoniae, the most significant group of diagnostic criteria identified included
absence of haemorrhagic rash (OR 13.62), positive gram stain (OR 2.10), coma (OR 3.11), seizures (OR 3.81) and peripheral
WBC$15000/mL (OR 2.19) with a PPV of 77.8% (95%CI 40.0–97.2). For the diagnosis of Haemophilus influenzae, the most
significant group of diagnostic criteria included, absence of haemorrhagic rash (OR 13.61), age$1year (OR 2.04), absence of
headache (OR 3.01), CSF Glu,40 mg/dL (OR 3.62) and peripheral WBC,15000/mL (OR 1.74) with a PPV of 58.5% (95%CI
42.1–73.7).
Conclusions: The use of clinical and laboratory predictors for the assessment of the causative bacterial pathogen rather
than just for predicting outcome of mortality seems to be a useful tool in the clinical management and specific treatment of
BM. These findings should be further explored and studied.
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Introduction
Meningitis is an inflammation of the meninges that may result in
response to several causes, most commonly bacteria and viruses.
Bacterial meningitis (BM) is a potentially life-threatening condition
if left untreated [1]. The potential for serious neurological damage
or even death necessitates prompt medical attentionand evaluation.
The introduction of new vaccines has altered the epidemiology
of meningitis over the last decades, mostly due to the introduction
of the Hib vaccine conjugate [2–5]. Fatality rates associated with
bacterial meningitis in children,14 years of age have been
documented in various studies confirming case fatality rates (CFR)
ranging from about 3% to 13% depending on the causative agent
[5–7]. The three most commonly presented bacterial pathogens
amongst infants and young children during the last decades can be
narrowed down to Neisseria meningitides, Streptococcus pneumoniae and
Haemophilus influenzae [2,4,5].
Several studies have been performed over the years exploring
prognostic factors and clinical features of adults, but most of these
studies had a relatively low study population [8–13]. Moreover,
only few studies of prognostic factors with respect to bacterial
meningitis in children have been reported [13,14]. Predictive
factors that have shown significant interest in the last decade with
respect to bacterial meningitis include Cerebral Spinal Fluid (CSF)
and peripheral blood white cell count (WCC) [15,16]. The values
of white cell count (WCC) have also been reported to predict
invasive disease in pneumococcal, Hib, and Neisseria infections
[17,18]. Interestingly prognostic factors of clinical and laboratory
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differentiation of bacterial from viral meningitis [19]. Certain
prognostic factors of invasive malarial disease that have been
shown to mimic meningism include fever, seizures and impaired
consciousness [20]. The importance of early recognition of
childhood bacterial meningitis through clinical and laboratory
findings continues to be a major concern for clinicians.
The present study was scheduled in an attempt to analyze in a
large cohort of samples, various clinical symptoms as well as rapid
laboratory results and provide an algorithm for the prediction of
specific bacterial aetiology of childhood bacterial meningitis. This
large series of cases allows for a complete descriptive analysis of
likely predictors for the potential causative agent of childhood
meningitis with precise confidence intervals, prior to lengthy
culture and laboratory results. This analysis may benefit clinicians
to better acknowledge a more accurate diagnosis of the causative
microbial pathogen in specific cases of meningitis.
Methods
Ethics Statement
This study was approved by the ethics committee of Aghia Sofia
Children’s Hospital.
Patient consent was not required since the data presented in this
study did not relate to any person or persons.
Definitions
A ‘‘BM case’’ was defined as any patient, aged 1 month to 14
years old, treated in the Infectious Diseases Department of Agia
Sophia Children’s Hospital Athens, Greece, from January 1st 1974
until December 31st 2005, diagnosed with bacterial meningitis.
Both ‘‘probable’’ and ‘‘confirmed BM cases’’ were included in the
Meningitis Registry (MR).
‘‘Probable’’ bacterial meningitis cases were defined - according to
World Health Organization (WHO) criteria as those presenting
clinical symptoms of meningitis (i.e. fever, headache, stiff neck,
bulging fontanelle or altered mental status) and CSF with an
elevated protein (.100 mg/dl), decreased glucose (,40 mg/dl) or
leukocytosis (.100 WBC/mm3) with at least 80% neutrophils and
lacking an identifiable bacterial pathogen [21]. Exclusion Criteria:
Patients with recurrent meningitis due to structural defects of the
central nervous system, or with Tuberculous meningitis were
excluded from the analysis. Patients less than one month old were
also excluded from the study.
‘‘Confirmed’’ bacterial meningitis cases were defined according to
WHO case definition criteria [21]: children presenting with
clinical symptoms of meningitis (i.e. fever, headache, stiff neck,
bulging fontanelle or mental status changes) and identification of
bacteria directly (by culture or PCR from blood or CSF, or by
culture from the petecchial lesions), or indirectly (by latex test,
countercurrent immunoelectrophoresis, Fadebact, or Gram stain
smear of blood or CSF). The ‘‘Confirmed’’ bacterial meningitis cases
were further divided into the following groups, representing the
most commonly isolated pathogens: Neisseria meningitidis, Strepto-
coccus pneumoniae, Haemophilus influenzae type b and a fourth group
‘‘confirmed bacterial meningitis due to other bacteria’’ including
all other isolated pathogens.
Diagnostic factors are defined as those variables that determine the
diagnosis of the patients’ disease. Fever was defined as body
temperature$38uC at presentation. Haemorrhagic rash was defined
as visible petecchiae on the face or body. Seizures were defined as
any convulsive disorder of any type on presentation of the patient
at hospital that did not previously exist in the patient’s history.
Bulging fontanelle was defined as any visible inflammation of the
fontanelle at presentation. Headache is defined as a pain in the head
with the pain being above the eyes or the ears, behind the head
(occipital), or in the back of the upper neck. Grunting was defined as
any verbal no coherent sounds made by the patient at
presentation. Poor feeding was defined as the loss of appetite as
stated by the parent in the case of infants and young children or by
the individual if the child was coherent (older children). Shock was
defined when the systolic blood pressure was measured as ,2
standard deviations (SD) of the age related mean value or in the
presence of severely decreased peripheral effusion during physical
examination. Coma was defined when patients were in a state of
profound unconsciousness incapable of sensing or responding to
stimuli, or, presenting with a Glascow Coma Scale (GCS),8. Other
Pathogens was defined as a series of bacteria including, group B
Streptococcus, Salmonella spp, Streptococcus spp, Pseudomonas aeruginosa,
Escherichia coli, Staphylococcus spp, Brucella melitensis, Klebsiella pneumo-
niae, Acinetobacter anitratus, Enterobacter cloaca, Mycoplasma pneumoniae,
Proteus spp and Rickettsiae spp.
Design
Referral Pattern. Aghia Sofia Children’s Hospital is one of
the leading paediatric hospitals in Greece, with an average of
20,000 admissions annually. The infectious disease department
treat approximately 4% of these admissions. The last decade in
Greece has seen a change in referral pattern with the
establishment of more paediatric clinics both private and within
general hospitals, leading to a more wide distribution of meningitis
cases. With respect to meningitis cases in Athens, it could be
postulated that Agia Sofia Hospital served about 100% of the
pediatric population of metropolitan Athens during 1974–1984,
approximately 65% during 1985–1994 and approximately 55%
during 1995–2005 [5].
Data were prospectively collected over a 32 year period (1974–
2005) through the Meningitis Registry (MR) of the Infectious
Diseases Department of Aghia Sofia Children’s Hospital [5]. The
Registry Forms (RF) consisted of a series of data including: clinical
and laboratory results regarding admission, hospital stay, treat-
ment, discharge diagnosis and sequelae. More importantly for the
purposes of this study, certain parameters were extracted from the
MR as described previously [5]. These parameters included age as
well as clinical features including headache, vomiting, meningeal
signs, haemorrhagic rash, seizures and coma, all of which were
considered as diagnostic factors. However emphasis on analysis
has been given to parameters available within the first 24 hrs from
presentation to hospital. However, the introduction of Hib vaccine
has significantly changed the referral pattern leading to a referral
bias with more severe cases of pneumococcal disease referred from
1994 onwards.
Participants
The study group consisted of patients aged from 1 month to 14
years. Only confirmed BM cases were included in the analysis.
Exclusion criteria have been stated in the definitions.
Data Analysis
Data of confirmed BM cases were gathered from the MR and
analyzed for its statistical significance using EPI INFO (version
3.4.3-CDC-Atlanta) and SPSS (version 15.0 - Chicago) software.
The chi-square and Fischer exact tests were used to compare
qualitative variables. Student t-test or Mann-Whitney test were
used for quantitative data. Univariate analysis of diagnostic factors
for all three pathogens as well as ‘‘others’’ was performed and their
Relative Risk (RR), Positive Predictive Value (PPV) as well as 95%
Confidence Intervals (95%CI) were calculated. Variables found by
Meningitis Laboratory Findings
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included in a conditional backward logistic regression model.
Results
Study population
A total of 2,477 ‘‘probable’’ bacterial meningitis cases were
recorded from the registry forms of ASCH of which 1,331 (53.7%)
cases were classified as confirmed BM cases. The three most
common pathogens isolated in this study were Neisseria meningitidis
with 838 cases (63.0%), Haemophilus influenzae type b with 252
(18.9%), and thirdly Streptococcus pneumoniae with 186 (14.0%). Other
bacteria accounted for 55 (4.1%) of meningitis cases (Table 1).
Demographics
The mean age of patients was 2.6 years (SD=3.3, range=1
month to 14 years). Mean duration of symptoms before hospital
admission was 42.2 hours (SD=37.4). Interestingly, 652 out of
691 (94.4%, 95%CI 92.3–95.9) patients presented with fever on
admission while 824 out of 1126 (73.2%, 95%CI 70.5–75.7)
patients showed evident meningeal signs. Positive CSF culture was
reported in 966 out of 1213 (79.6%, 95%CI 77.2–81.8) of cases,
while positive blood cultures were reported with a lower frequency
of 279 out of 928 cases (30.1%, 95%CI 27.1–33.1).
Characteristics of the study population are presented in Table 2.
From a total of 706 cases of confirmed Neisseria meningitidis 525
(74.4%) cases presented with meningeal signs. Confirmed Streptococcus
pneumoniae cases totaling 165 cases accounted for 140 (84.8%) of
patients presenting with positive CSF gram results. The most
common finding in patients with confirmed Haemophilus influenze
was CSF Glucose,40 mg/dL 195/248 (78.6%) (Table 3).
Neisseria meningitidis
Neisseria meningitidis was confirmed as being responsible for 838
(63.0%) cases of meningitis in our study. Upon initial presentation
of patients, the presence of Neisseria meningitidis was positively
associated with CSF WBC#100/mL (RR 1.47, 95%CI 1.36–1.58)
(Table 4), the presence of haemorrhagic rash (RR 2.23, 95%CI
2.05–2.43), with a PPV of 93.4% (95%CI 90.9–95.3) and with the
presence of headache (RR 1.31, 95%CI 1.19–1.44) with a PPV of
73.8% (95%CI 69.6–77.6) (Table 5).
Haemorrhagic rash was the most important diagnostic factor for
the differentiation of Neisseria meningitidis as the causative organism
of meningitis (Figure 1). With respect to diagnosis of Meningo-
coccal meningitis, a negative association was noted for the
diagnostic criteria including positive gram stain (RR 0.78,
95%CI 0.71–0.85, p,0.001), CSF Glu,40 mg/dL (RR 0.71,
95%CI 0.66–0.78, p,0.001), seizures (RR 0.65, 95%CI 0.54–
0.76, p,0.001), bulging fontanelle (RR 0.73, 95%CI 0.64–
0.84,p,0.001) and grunting (RR 0.74, 95%CI 0.66–0.83,
p,0.001)(Tables 4 and 5). Moreover the strongest association
with the diagnosis of Meningococcal meningitis was noted with a
group of diagnostic criteria including haemorrhagic rash (OR
22.36, 95%CI 13.12–38.11), absence of seizures (OR 2.51, 95%CI
1.51–4.18), headache (OR 1.83, 95%CI 1.13–2.65) and negative
gram stain (OR 1.55, 95%CI 1.02–2.34) with a PPV of 96.4%
(95%CI 87.7–99.6) (Table 6).
Haemophilus influenzae type b
Haemophilus influenzae was noted as being the second most
frequent cause of bacterial meningitis in our study with 252
confirmed cases (18.9%) and a case fatality rate of 0.8% (95%CI
0.1–2.8) (Table 1).
CSF Glu,40 mg/dL predicted a positive association for the
presence of Haemophilus influenzae (RR 2.80, 95%CI 2.11–3.72,
PPV 27.3%, 95%CI 24.1–30.8) (Table 4). On the contrary, CSF
WBC#1000/mL (RR 0.34, 95%CI 0.25–0.48), was negatively
associated with the diagnosis of Haemophilus influenzae as was
headache (RR 0.45, 95%CI 0.34–0.60) and haemorrhagic rash
(RR 0.10 95%CI 0.06–0.17) (Table 4 and 5).
The strongest association of a group of diagnostic factors with
the diagnosis of Haemophilus influenzae within the first 24 hrs of
admission, included absence of haemorrhagic rash (OR 13.61,
95%CI 6.93–26.72 ), age$1 year (OR 2.04 ,95%CI 1.25–3.31),
absence of headache (OR 3.01, 95%CI 1.89–4.80) , CSF
Glu,40 mg/dL (OR 3.62, 95%CI 2.32–5.66) and Peripheral
WBC,15000 mL (OR 1.74, 95%CI 1.15–2.63) with a PPV of
58.5% (95%CI 42.1–73.7)(Table 7). For the exclusion of
Haemophilus influenzae, diagnostic criteria with the strongest
association included haemorrhagic rash (OR 13.46, 95%CI
7.35–24.66) and headache (OR 2.38, 95%CI 1.65–3.43) with a
PPV of 97.9% (95%CI 95.2–99.3) (Table 7). Overall, CSF
Glu,40 mg/dL had the strongest association with the diagnosis of
Haemophilus influenzae (Figure 1).
Streptococcus pneumoniae
Streptococcus pneumoniae was noted as the third most significant
causative pathogen of bacterial meningitis with 186 confirmed
cases (14.0%). Streptococcus pneumoniae was responsible for 7.5%
(95%CI 4.2–12.3) of case fatalities (Table 1).
Table 1. Number of confirmed cases and Case Fatality Rates (CFR) of the most common aetiological pathogens of meningitis
throughout 1974–2005.
Organism 1974–2005
Confirmed Cases Case Fatalities
N % N %CFR (95%CI) Relative Risk (95% CI)
N. meningitidis 838/1331 63.0 14 1.7 (1.0–2.9) 0.3 (0.2–0.6)
S. pneumoniae 186/1331 14.0 14 7.5 (4.2–12.3) 2.1 (1.2–3.7)
H. influenzae type b 252/1331 18.9 2 0.8 (0.1–2.8) 0.2 (0.0–0.8)
Other bacteria* 55/1331 4.1 4 7.3 (2.0–17.6) 1.9 (0.7–5.1)
Total 1331 - 34 2.6 -
*group B Streptococcus, Salmonella spp, Streptococcus spp, Pseudomonas aeruginosa, Escherichia coli, Staphylococcus spp, Brucella melitensis, Klebsiella pneumoniae,
Acinetobacter anitratus, Enterobacter cloaca, Mycoplasma pneumoniae, Proteus spp, Rickettsiae spp.
doi:10.1371/journal.pone.0006426.t001
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of Streptococcus pneumoniae as the causative agent of bacterial
meningitis with a Relative risk (RR 2.61, 95%CI 1.74–3.92) and
a PPV of 17.9% (95%CI 15.3–20.8). Similarly Peripheral
WBC$15000/mL was also positively associated (RR 1.55,
95%CI 1.17–2.04) with a PPV of 17.0% (95%CI 14.0–20.5)
(Table 4). The strongest association was noted with the presence of
seizures at initial presentation (RR 3.28, 95%CI 2.45–4.38) with a
PPV of 32.3% (95%CI 25.9–39.3) (Table 5). Moreover, seizures
were noted as the most significant diagnostic factor for the
diagnosis of Streptococcus pneumoniae (Figure 1).
A group of diagnostic factors with the strongest association for
the diagnosis of Streptococcus pneumoniae included absence of
haemorrhagic rash (OR 13.62, 95%CI 5.72–32.31), positive gram
stain (OR 2.10, 95%CI 1.23–3.92), coma (OR 3.11, 95%CI 1.56–
6.17), seizures (OR 3.81, 95%CI 2.22–6.53) and peripheral
WBC$15000/mL (2.19 95%CI 1.36–3.53), with a PPV of
77.8% (95%CI 40.0–97.2) (Table 8).
Other pathogens
A series of bacteria as defined above have all been grouped together
as ‘other pathogens’ for the purpose of statistical analysis. As causative
agents of bacterial meningitis, this group of bacteria were lower in
frequency than that of H.influenzae, S.pneumoniae and N.meningitidis as
seen in Table 1 with a total of 55 (4.1%) confirmed cases.
Associations between ‘other pathogens’ as the contributing
organism for bacterial meningitis with diagnostic criteria are
shown in Tables 4, and 5. Age,1 year was noted to have the
strongest association with the diagnosis of ‘other pathogens’ with a
RR 6.64 (95%CI 3.53–12.50) (Table 5).
The group of diagnostic variables with the strongest association
with the diagnosis of ‘other pathogens’ included age,1year (OR
4.35, 95%CI 1.82–10.39), absence of haemorrhagic rash (OR
21.51, 95%CI 2.87–161.18), negative gram stain (OR 3.46,
95%CI 1.64–7.29) and absence of meningeal signs (OR 3.37,
95%CI 1.51–7.41) with a PPV of 37.9% (95%CI 20.7–57.7)
(Table 9). For the diagnosis of ‘other pathogens’ the highest PPV
of 9.3% was calculated for age,1 year (Table 10). Overall, age,1
year and absence of haemorrhagic rash were noted as the most
significant diagnostic factors for the diagnosis of ‘other pathogens’.
Discussion
With the introduction of conjugate vaccines, overall mortality of
childhood meningitis has been shown to be considerably decreased
over the last decade [3,7]. We present results of our study of data
totalling 2,477 probable bacterial meningitis cases of patients, aged
between 1 month and 14 years of age admitted with meningitis from
a large paediatric teaching hospital in Greece. From these, a total of
1,331 cases were confirmed as bacterial meningitis. Analysis of data in
this study has been restricted to confirmed BM cases only. This study
was designed to investigate the likelihood of predetermining the
causative bacterial pathogen by analysing a series of clinical
symptoms at presentation and laboratory findings available within
the first day of admission. Emphasis has been given to diagnostic
factors that are readily available within the first 24 hrs of admission.
Our results show that the three most common causative pathogens
associated with bacterial meningitis in this study included Neisseria
meningitidis (63.0%), Streptococcus pneumoniae (14.0%), Haemophilus
influenzae (18.9%) and ‘other pathogens’ (4.1%). Only half of the
probable bacterial cases were actually confirmed as bacterial
meningitis. This may be attributed to the management protocol that
exists in Greece to administer antibiotic therapy for any suspected
meningitis cases. Hence, some bacterial in origin meningitis cases are
missed when positive culture results are unobtainable and never
confirmed. Interestingly, other studies have reported lower recovery
rates for confirmed Haemophilus influenzae as a causative organism of
meningitis while others report higher case fatality rates of bacterial
meningitis than those presented in this study [22,23]. Interestingly,
the lack of clinical features of meningial irritation in the three main
groups may probable reflect age.
With respect to clinical features as diagnostic factors, few studies
in adults exist for the analysis of favourable, unfavourable
diagnosis and sequelae [8,24,25]. Even fewer studies deal with
childhood meningitis. Interestingly, to the best of our knowledge
there are no publications to date with respect to predetermination
of the causative pathogen of bacterial meningitis through the use
of clinical or laboratory findings.
Neisseria meningitidis
Over the past three decades Neisseria meningitidis has been the
most common causative pathogen of meningitis in Greece as was
also confirmed in our study [5]. Other studies, from other
Table 2. Characteristics of the study population.
Variable N/Total or Mean (SD) Percentage (95% CI)
Demographics
Age (y) 2.6 (3.3)
Male sex 759/1328 57.2% (54.4–59.8)
Mean duration of symptoms (h) 42.2 (37.4)
Duration of symptoms,24 h 256/1153 22.2% (19.9–24.1)
Mean body temperature (uC) 39.1 (0.83)
Fever 652/691 94.4% (92.3–95.9)
Headache 496/952 52.1% (48.9–55.3)
Vomiting 678/1134 59.8% (56.9–62.6)
Meningeal signs 824/1126 73.2% (70.5–75.7)
Haemorrhagic rash 547/1329 41.2% (38.5–43.9)
Seizures 201/981 20.5% (18.0–23.2)
Bulging fontanelle 278/901 30.9% (27.9–34.0)
Grunting 357/955 37.4% (34.3–40.5)
Poor feeding 294/888 33.1% (30.0–36.3)
Shock 116/933 12.4% (10.4–14.8)
Coma 94/924 10.2% (8.3–12.3)
White-cell count (cells/mm
3) 4918.9 (7452.5)
#100 WBC/mm
3 198/1304 15.2% (13.3–17.3)
#1000 WBC/mm
3 436/1304 33.4% (30.9–36.1)
% polymorphonuclears 84.7 (17.2)
% lymphocytes 15.3 (16.1)
Glucose (mg/dl) 36.0 (33.9)
Potein (mg/dl) 161.9 (156.2)
Positive CSF culture 966/1213 79.6% (77.2–81.8)
Positive CSF Gram stain 784/1149 68.2% (65.4–70.9)
White-cell count 15072.7 (8181.5)
% polymorphonuclears 69.7 (18.4)
% lymphocytes 21.8 (16.3)
CRP (mg/l) 140.7 (87.9)
Haemoglobin 10.9 (1.5)
Haematocrit 33.9 (4.3)
Positive Blood culture 279/928 30.1% (27.1–33.1)
doi:10.1371/journal.pone.0006426.t002
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Neisseria meningitidis as the causative pathogen for childhood
meningitis [15]. Although the introduction of polysaccharide and
conjugate vaccines have managed to change the epidemiology of
meningitis in many countries, the emergence of Neisseria as a
causative pathogen for meningitis continues to prevail [26].
Therefore it is important that we do not dismiss this pathogen
as an ongoing concern. We determine that the presence of
haemorrhagic rash is a significant diagnostic indicator for the
diagnosis of Neisseria meningitidis. The most significant group of
diagnostic criteria for the diagnosis of Meningococcal meningitis
included haemorrhagic rash, absence of seizures, headache and
negative gram stain with a PPV 96.4%. Haemorrhagic rash is a
diagnostic factor that is easily noted by clinicians during initial
presentation of patients without any delays from laboratories. The
presence of haemorrhagic rash is a common sign of bacterial
meningitis that has been well documented in other studies
[8,27,28]. Haemorrhagic rash has also been associated with other
bacteraemia. Interestingly, from our study it was noticed that from
the cases presenting with no rash and CSF WCC,100/mL,
Neisseria meningitidis was confirmed to be the causative organism of
meningitis in 50% of cases. This continues to be a diagnostic
dilemma that should be further explored. Overall from our study,
it is apparent that the presence of haemorrhagic rash on
presentation is by far the most positively statistically significant
diagnostic factor for the diagnosis of Neisseria meningitidis.
Haemophilus influenzae
The introduction of the Hib vaccine in Greece during 1993 and
other countries revealed a decline of Haemophilus influenzae type b as
the causative pathogen of meningitis [5,29,30]. Haemophilus
influenzae type b continues to cause meningitis in Greece with a
confirmed case rate of 18.9%. These findings are consistent with
results from other studies in other countries [15,31,32]. However,
findings of some other countries quote Haemophilus influenzae as still
being the primary causative pathogen for meningitis [33,34].
Our study also identifies CSF glucose,40 mg/dL and age$1
year as important diagnostic factors for the outcome of Haemophilus
influenzae. CSF glucose has been presented in the literature with
respect to sequelae and mortality but not for the direct
predetermining of Haemophilus influenzae as the causative pathogen
[14,35]. CSF glucose has also been previously stated as a
parameter for the differentiation between bacterial meningitis
and Tuberculous meningitis [36]. The lower glucose in Haemophilus
influenzae type b may possibly be an indirect measure of the level of
acuity that differs from pneumococcus and meningococcus.
Clinical and laboratory results may also be applied for the exclusion
of Haemophilus influenzae type b as the causative agent. The analysis of
initial presentation showing signs of headache and symptoms of
haemorrhagic rash revealed a PPV value for non Hib bacterial
meningitis of 97.9% (95%CI 95.2–99.3). This may aid clinicians to
apply appropriate antibiotic therapy in the case where they may
strongly suspect Haemophilus influenzae type b as the causative pathogen.
Overall it is apparent that the absence of haemorrhagic rash
rather than its presence, as well as CSF Glu,40 mg/dL are
essential predictors for the diagnosis of Haemophilus influenzae type b.
Streptococcus pneumoniae
Streptococcus pneumoniae is the third world wide most common
aetiology of bacterial meningitis with high mortality rates
[2,5,8,10,12,37]. The introduction of Hib vaccine has significantly
changed the referral pattern leading to a referral bias with more
Table 3. Frequency of clinical and laboratory findings for specific bacterial pathogen.
VARIABLES N.MENINGITIDIS S. PNEUMONIAE H. INFLUENZAE OTHER
n/Total% (95% CI) n/Total% (95% CI) n/Total% (95% CI) n/Total% (95% CI)
Age,1 year 223/814 74/181 102/247 41/53
27.4 (24.4–30.6) 40.9 (33.6–48.4) 41.3 (35.1–47.7) 77.4 (63.8–87.7)
Headache 366/623 65/122 57/174 8/33
58.7 (54.8–62.6) 53.3 (44.0–62.4) 32.8 (25.8–40.3) 24.2 (11.1–42.3)
Meningeal signs 525/706 118/154 167/225 14/41
74.4 (70.9–77.5) 76.6 (69.1–83.1) 74.2 (68.0–79.8) 34.1 (20.1–50.6)
Haemorrhagic rash 511/838 17/185 17/252 2/54
61.0 (57.6–64.3) 9.2 (5.4–14.3) 6.7 (4.0–10.6) 3.7 (0.5–12.7)
Seizures 85/596 65/142 39/201 12/42
14.3 (11.6–17.4) 45.8 (37.4–54.3) 19.4 (14.2–25.6) 28.6 (15.7–44.6)
Coma 51/574 28/129 15/188 0/33
8.9 (6.7–11.6) 21.7 (14.9–29.8) 8.0 (4.5–12.8) 0.0 (0.0–10.6)
Positive CSF Gram stain 451/721 140/165 173/222 20/41
62.6 (58.9–66.1) 84.8 (78.5–89.9) 77.9 (71.9–83.2) 48.8 (32.9–64.9)
CSF WBC,100 mm
3 170/817 16/181 3/252 9/54
20.8 (18.1–23.8) 8.8 (5.1–14.0) 1.2 (0.2–3.4) 16.7 (7.9–29.3)
Peripheral WBC$15000/mL 369/796 95/171 82/236 13/51
46.4 (42.9–49.9) 55.6 (47.8–63.1) 34.7 (28.7–41.2) 25.5 (14.3–39.6)
CSF Glucose,40 mg/dl 382/789 103/169 195/248 33/50
48.4 (44.9–52.0) 60.9 (53.2–68.3) 78.6 (73.0–83.6) 66.0 (51.2–78.8)
*Missing values have been excluded from the analysis.
doi:10.1371/journal.pone.0006426.t003
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Streptococcus pneumoniae accounted for the highest case fatality rate in
this study (7.5%), while it was recorded as the third most common
cause of bacterial meningitis.
Variables including coma, seizures and positive gram stain were
strongly associated with the diagnosis of Streptococcus pneumoniae.
The direct significance of the presence of seizures and coma at
presentation with pneumococcal meningitis and unfavourable
Figure 1. The use of significant prognostic factors (Hemorrhagic rash, Seizures, CSF Glucose,40 mg/dL and Patient,1year), for the
predetermination of the diagnosis of bacterial meningitis.
doi:10.1371/journal.pone.0006426.g001
Table 6. Multivariate analysis of diagnostic factors for the diagnosis of Neisseria meningitidis.
Diagnostic Factors Neisseria meningitidis
OR 95%CI P % PPV 95%CI %NPV 95%CI
Haemorrhagic rash 25.00 14.94–41.83 ,0.001
Absence of seizures 2.49 1.54–4.04 ,0.001
Headache 1.91 1.34–2.71 0.001
Haemorrhagic rash+Absence of Seizures+Headache 94.3 89.5–97.4 41.3 38.5–44.2
Haemorrhagic rash 22.36 13.12–38.11 ,0.001
Absence of seizures 2.51 1.51–4.18 ,0.001
Headache 1.83 1.13–2.65 0.001
Negative gram stain 1.55 1.02–2.34 0.040
Haemorrhagic rash+Absence of seizures+Headache+Negative gram stain 96.4 87.7–99.6 38.5 35.8–41.3
Haemorrhagic rash 21.5 13.62–33.93 ,0.001
Headache 2.04 1.48–2.81 0.008
Haemorrhagic rash+Headache 94.2 90.5–96.8 44.0 41.0–47.0
doi:10.1371/journal.pone.0006426.t006
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Other studies have also dealt with various clinical and laboratory
findings as prognostic factors with respect to fatal outcome
[37,38,39]. This present study however confirms that these
variables can also be used as diagnostic factors in the pre-
determination of Streptococcus pneumoniae as the causative organism.
Seizures are an important predetermining factor for the diagnosis
of Streptococcus pneumoniae. This is quite significant as such diagnostic
factors may guide clinicians towards Streptococcus pneumoniae as the
causative bacterial pathogen without the lengthy wait of culture
results. This in turn will aid in reducing mortality rates as
appropriate treatment for Streptococcus pneumoniae may be admin-
istered early. Another study explores a group of clinical symptoms
including seizures to predict the diagnosis of malaria [20]. From
such studies we may hypothesize that clinical features may actually
play a significant role in diagnosis of causative bacterial organisms.
Notably, Seizures were not statistically significant for the
diagnosis of Haemophilus influenzae, therefore aiding in the
differentiation between Streptococcus pneumoniae and Haemophilus
influenzae type b. This result coincides with findings from another
study where generalised seizures in children did not show strong
prediction of bacterial meningitis [40].
Other Pathogens
In our study a series of bacteria as described earlier were
grouped together as ‘other pathogens’ as their frequency as
individual causative organisms for meningitis were lower than the
three bacteria named above. Bacteria such as Group B streptococcus,
Staphylococci, Escherichia coli, Klebsiella pneumoniae, Listeria monocytogenes,
and other gram negative bacilli all appear infrequently as causative
pathogens of meningitis [15,41,42,43].
The strongest association with the diagnosis of ‘other pathogens’
was patient Age,1 year. This is a significant finding for the pre-
diagnosis of uncommon bacterial meningitis. Mortality rates of such
bacteria have been quoted as high as 7.3% with an average stay in
hospital of about 20 days, hence the ability to predetermine such
bacteria prior to culture isolation is essential for clinicians [5]. Age is
a factor that has been used by clinicians in order to orientate the
appropriate clinical symptoms of meningitis for quite some time.
The use of age as a clinical variable has also been applied in rules
proposed by other authors for the prediction and differentiation of
acute bacterial meningitis from viral meningitis [44,45].
Certain limitations to our study include the incidence of specific
bacterial meningitis that has been noted to change from country to
country as well as region to region within the same country
[22,33,46]. During the period of study, Greece presented the
above mentioned incidences of disease, with Neisseria meningitidis
leading the way of meningitis. Our study concentrates on the
diagnostic factors associated with meningitis disease in Greece
only. The same principle may be applied to other countries,
however the results may differ as the incidence of disease is known
to differ from country to country. The use of antibiotic therapy
prior to bacterial confirmation of meningitis may also affect the
results of this study giving a false confirmed study population. If
this is the case then the true figure of bacterial meningitis would be
expected to be higher. Positive predictive value is indirectly
proportional to incidence of specific bacterial meningitis disease
and is therefore expected to vary as incidence of disease varies
from country to country.
Many third world countries do not have the availability of fully
equipped diagnostic laboratories to aid in culture diagnosis, and
therefore rely almost entirely on clinical features, symptoms and
simple laboratory findings to make a diagnosis. Previous studies
Table 7. Multivariate analysis of groups of diagnostic factors for the diagnosis of Haemophilus influenzae type b.
Diagnostic Factors Haemophilus influenzae type b
OR 95%CI P % PPV 95%CI % NPV 95%CI
Absence of haemorrhagic rash 13.00 6.82–24.76 ,0.001
Age$1 year 1.84 1.16–2.74 0.010
Absence of headache 3.09 1.97–4.85 ,0.001
CSF Glu,40 mg/dL 3.49 2.26–5.40 ,0.001
Absence of haemorrhagic rash+Age$1 year+Absence of headache+CSF Glu,40 mg/dL 54.4 41.9–66.5 83.0 80.8–85.0
Absence of heamorrhagic rash 13.61 6.93–26.72 ,0.001
Age$1 year 2.04 1.25–3.31 0.004
CSF Glu,40 mg/dL 3.62 2.32–5.66 ,0.001
Absence of headache 3.01 1.89–4.80 ,0.001
Peripheral WBC,15000/mL 1.74 1.15–2.63 ,0.001
Absence of heamorrhagic rash+Age$1 year+CSF Glu,40 mg/dL+Absence of
headache+Peripheral WBC,15000/mL
58.5 42.1–73.7 82.0 80.1–84.3
Absence of haemorrhagic rash 11.09 6.01–20.46 ,0.001
CSF Glu,40 mg/dL 3.09 2.03–4.69 ,0.001
Absence of headache 2.27 1.55–3.32 ,0.001
Haemorrhagic rash+CSF Glu,40 mg/dL+Absence of headache 44.4 37.2–51.8 85.3 83.1–87.3
Non Haemophilus influenzae type b
Haemorrhagic rash 13.46 7.35–24.66 ,0.001
Headache 2.38 1.65–3.43 ,0.001
Haemorrhagic rash+Headache 97.9 95.2–99.3 22.7 20.2–25.3
doi:10.1371/journal.pone.0006426.t007
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Diagnostic Factors Streptococcus pneumoniae
OR 95%CI P % PPV 95%CI % NPV 95%CI
Absence of haemorrhagic rash 15.12 6.50–35.16 ,0.001
Coma 3.17 1.70–5.89 ,0.001
Seizures 3.08 1.91–4.98 ,0.001
Absence of haemorrhagic rash+Coma+Seizures 73.1 52.2–88.4 87.2 85.2–88.9
Absence of haemorrhagic rash 13.62 5.72–32.31 ,0.001
Positive gram stain 2.10 1.23–3.92 0.019
Coma 3.11 1.56–6.17 0.001
Seizures 3.81 2.22–6.53 ,0.001
Peripheral WBC$15000/mL 2.19 1.36–3.53 0.001
Absence of haemorrhagic rash+Positive gram stain+Coma+Seizures+Peripheral WBC$15000/mL 77.8 40.0–97.2 86.5 84.5–88.2
Coma 2.47 1.35–4.57 0.003
Seizures 3.65 2.27–5.87 ,0.001
Positive gram stain 2.70 1.51–4.84 ,0.001
Coma+Seizures+Positive gram stain 57.7 36.9–76.6 86.9 84.9–88.7
Coma 2.71 1.47–4.80 0.002
Seizures 4.03 2.43–6.70 ,0.001
Positive gram stain 2.65 1.47–4.80 0.001
Peripheral WBC$15000/mL 1.87 1.19–2.95 0.007
Coma+Seizures+Positive gram stain+Peripheral WBC$15000/mL 58.3 27.7–84.8 86.4 84.4–88.2
Coma 3.12 1.74–5.60 ,0.001
Seizures 3.69 2.28–5.97 ,0.001
Peripheral WBC$15000/mL 1.69 1.11–2.59 0.015
Coma+Seizures+Peripheral WBC$15000/mL 60.0 32.3–83.7 86.6 84.6–88.3
doi:10.1371/journal.pone.0006426.t008
Table 9. Multivariate analysis of groups of diagnostic factors for the diagnosis of ‘other pathogens’.
Diagnostic Factors Other pathogens
OR 95%CI P %PPV 95%CI %NPV 95%CI
Age,1year 4.25 1.92–9.42 ,0.001
Absence of haemorrhagic rash 9.96 2.36–42.05 0.002
Absence of meningeal signs 3.68 1.78–7.54 ,0.001
Age,1year+Absence of haemorrhagic rash+Absence of Meningeal signs 20.0 13.3–28.3 97.4 96.3–98.2
Age,1year 4.35 1.82–10.39 ,0.001
Absence of haemorrhagic rash 21.51 2.87–161.18 0.003
Negative gram stain 3.46 1.64–7.29 0.001
Absence of meningeal signs 3.37 1.51–7.41 0.003
Age,1year+Absence of haemorrhagic rash+Negative gram stain+Absence of meningeal signs 37.9 20.7–57.7 96.6 95.5–97.5
Age,1year 5.65 2.41–13.26 ,0.001
Negative gram stain 2.65 1.28–5.48 0.008
Absence of meningeal signs 3.24 1.48–7.07 0.003
Age,1year+Negative gram stain+Absence of meningeal signs 24.4 12.9–39.5 96.6 95.4–97.5
Age,1year 5.37 2.55–11.30 ,0.001
Negative gram stain 3.48 1.79–6.77 ,0.001
Absence of haemorrhagic rash 27.39 3.71–202.50 0.001
Age,1year+Negative gram stain+Absence of haemorrhagic rash 22.2 12.7–34.5 96.8 95.6–97.6
doi:10.1371/journal.pone.0006426.t009
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differentiating bacterial from viral meningitis via scoring systems
[19, 36, 40, 48]. The use of such scoring systems to validate low
and high risk meningitis in conjunction to the use of clinical
features as diagnostic factors may aid in the predetermining of not
only bacterial meningitis outcome, but also in the categorisation of
the causative pathogen.
In an attempt collectively summarize the diagnostic criteria that
have been analysed in this study, it is possible to schematically
present a simplified diagram where the most significant diagnostic
factors are exploited to enable a possible predetermination of the
specific causative bacterial pathogen in suspected meningitis cases
upon initial presentation. Haemorrhagic rash is presented for the
determination of Neisseria meningitidis, CSF glucose,40 mg/dL for
the determination of Haemophilus influenzae type b, seizures for the
differentiation of Streptococcus pneumoniae and patient,1year for the
diagnosis of ‘other pathogens’. Further similar data evaluation
(clinical and laboratory) from different settings by clinicians and
scientists will strengthen the notion that the use of clinical and
laboratory findings are feasible in predetermining bacterial
meningitis. This schematic diagram is merely but a representation
of what could possibly be used as a tool by clinicians in the aid to
guide them to appropriate early antibiotic therapy.
Conclusion
Meningitis will continue to be the cause of mortality in many
countries as we continue to see changes in epidemiology of
meningitis with the introduction of new vaccines. However
bacterial pathogens will continue to surprise us with their existence
due to antimicrobial resistance. For this reason, it is important that
we find ways to promptly treat patients as accurately as possible,
for the most likely pathogen as soon as they present in hospital,
thereby reducing mortality rates. Diagnostic criteria have been
detailed in few studies and we believe that our study will enlighten
others to use clinical and laboratory predictors for the predeter-
mination of bacterial pathogens rather than just for mortality.
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